Numerical dosimetry ELF: accuracy of the method, variability of models and parameters, and the implication for quantifying guidelines
- PMID: 17495652
- DOI: 10.1097/01.HP.0000251249.00507.ca
Numerical dosimetry ELF: accuracy of the method, variability of models and parameters, and the implication for quantifying guidelines
Abstract
In situ electric fields and current densities are investigated by numerical simulations for exposure to ELF electric and magnetic fields. Computations are based on the finite-difference time-domain method (FDTD). The computational uncertainty is determined by comparison of analytical and numerical results and amounts to a worst-case expanded uncertainty (95% confidence interval) of +/-9.89 dB for both dosimetric quantities (E, J). Detailed investigations based on the Visible Human body model with a resolution of 2 mm show a strong influence of the tissue boundaries on the simulation results, which is caused by the numerical method. For the tissue specific in situ electric field and current density changes in excess of 10 dB are observed when comparing the results with and without evaluation of the dosimetric quantities at tissue boundaries. Moderate sensitivities with respect to tissue boundaries are observed only for low conductivity tissues when evaluating the in situ electric field whereas this behavior is observed for high conductivity tissues when evaluating the current density. For exposure to a 50 Hz magnetic field corresponding to the ICNIRP reference level, the simulated current density for central nervous system (CNS) tissue is in compliance with the ICNIRP guidelines. Exposure to a 50 Hz electric field may exceed the ICNIRP basic restriction for CNS tissue at least in a worst-case scenario (grounded human body, vertical electric field, tissue boundaries included for the evaluation of the current density). The in situ electric field is the more stable dosimetric quantity with respect to changes of the tissue conductivity of the Visible Human body model. The maximum conductivity sensitivity coefficient amounts to +122% for the current density whereas the maximum sensitivity coefficient for the in situ electric field is -20%. For electric field exposure the in situ electric field remains comparable (-6% to -4%), the averaged current density change ranges from -57% to -16% for the tissues under investigation. Magnetic field exposure of a scaled model of a five year old child leads to a decrease of the dosimetric quantities (J: -74% to -45%, E: -42% to -23%) compared to the Visible Human results.
Similar articles
-
Different basic dosimetric quantities for the characterization of exposure to low-frequency electric and magnetic fields and the implication for practical exposure conditions and guidelines.Health Phys. 2007 Jun;92(6):515-20. doi: 10.1097/01.HP.0000265310.91325.80. Health Phys. 2007. PMID: 17495651 Review.
-
Requirements for reliable worst-case assessment of human exposure to RF electromagnetic fields with known uncertainty.Health Phys. 2007 Jun;92(6):554-64. doi: 10.1097/01.HP.0000265219.86389.cf. Health Phys. 2007. PMID: 17495656 Review.
-
Assessment of complex EMF exposure situations including inhomogeneous field distribution.Health Phys. 2007 Jun;92(6):531-40. doi: 10.1097/01.HP.0000250620.32459.4c. Health Phys. 2007. PMID: 17495653 Review.
-
Dosimetric comparison between different quantities for limiting exposure in the RF band: rationale and implications for guidelines.Health Phys. 2007 Jun;92(6):547-53. doi: 10.1097/01.HP.0000236788.33488.65. Health Phys. 2007. PMID: 17495655 Review.
-
Static fields: biological effects and mechanisms relevant to exposure limits.Health Phys. 2007 Jun;92(6):584-90. doi: 10.1097/01.HP.0000232776.94463.c4. Health Phys. 2007. PMID: 17495659
Cited by
-
The role of the JAK2-STAT3 pathway in pro-inflammatory responses of EMF-stimulated N9 microglial cells.J Neuroinflammation. 2010 Sep 9;7:54. doi: 10.1186/1742-2094-7-54. J Neuroinflammation. 2010. PMID: 20828402 Free PMC article.
-
The Potential of Magnetic Nanoparticles for Diagnosis and Treatment of Cancer Based on Body Magnetic Field and Organ-on-the-Chip.Adv Pharm Bull. 2019 Aug;9(3):360-373. doi: 10.15171/apb.2019.043. Epub 2019 Aug 1. Adv Pharm Bull. 2019. PMID: 31592054 Free PMC article. Review.
Publication types
MeSH terms
LinkOut - more resources
Full Text Sources
Medical
Miscellaneous